Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2021   24,850,261      
Beginning balance at Dec. 31, 2021 $ 21,128,149 $ 24,850 $ 57,016,859 $ (35,833,621) $ (79,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 95,707   95,707    
Distributions to non-controlling interest 15,640       (15,640)
Net income (10,159)     (89,409)  
Net income (loss) 99,568       10,159
Ending balance (shares) at Mar. 31, 2022   24,850,261      
Ending balance at Mar. 31, 2022 21,307,784 $ 24,850 57,112,566 (35,744,212) (85,420)
Beginning balance (shares) at Dec. 31, 2022   24,850,261      
Beginning balance at Dec. 31, 2022 18,987,750 $ 24,850 57,351,008 (38,281,548) (106,560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 77,348   77,348    
Net income (18,060)     1,490,029  
Net income (loss) (1,471,969)       18,060
Ending balance (shares) at Mar. 31, 2023   24,850,261      
Ending balance at Mar. 31, 2023 $ 17,593,129 $ 24,850 $ 57,428,356 $ (39,771,577) $ (88,500)